Viome Life Sciences introduced it had raised $67 million in Sequence C funding led by Daring Capital Group.
The brand new funding, which included participation from current traders Khosla Ventures, West River Group, Glico, Ocgrow Ventures and Doctor Companions, brings the corporate’s increase to greater than $150 million.
Viome provides intestine microbiome exams for shoppers and gives diet suggestions primarily based on outcomes. It additionally obtained FDA Breakthrough Device Designation final 12 months for its mRNA evaluation expertise and synthetic intelligence platform that goals to detect early indicators of oral and throat cancers. The Breakthrough Devices program is not a advertising and marketing authorization from the FDA, although the objective is to hurry the event and evaluation of merchandise to deal with or diagnose life-threatening or debilitating ailments or circumstances.
Viome plans to make use of the capital to launch a brand new line of exams centered on the oral microbiome. The corporate raised $54 million last year and expanded its partnership with GlaxoSmithKline to analysis and doubtlessly develop interventions for some cancers and autoimmune ailments.
Genomic testing firm Variantyx introduced in $20 million in debt financing from Kreos Capital.
The startup provides genomic testing and analytics for uncommon genetic problems, reproductive well being and precision oncology. Earlier this 12 months, Variantyx introduced a $41.5 million C-2 funding round.
“Variantyx has constructed a singular and superior platform for precision drugs and its potential to course of the entire genome units it aside within the genomic diagnostics market. Our funds, which improve the corporate’s already robust capital place, will permit it to considerably scale up its industrial efforts,” Aris Constantinides, common accomplice of Kreos Capital, stated in a press release.
In-person and digital psychological well being supplier Aware Care scooped up $7 million in a Sequence B spherical led by Sopris Capital.
Others collaborating within the increase embody the College of Chicago, the Caruso Basis and the Venkon Group. The startup announced a $2.7 million Series A a 12 months in the past and a $1.5 million family and friends spherical in 2020.
Aware Care will use the Sequence B to develop in areas together with the Midwest and Southeast, launch particular person remedy and habit therapy applications, and proceed to develop its expertise.
Rhino Well being, which provides a platform that permits researchers and healthcare AI builders to entry and collaborate round various datasets, introduced a $6.7 million extension to its seed spherical final week.
Fusion Fund and LionBird Ventures co-led the spherical with participation from Qiming Enterprise Companions, Maccabi Well being Companies and Arkin Holdings.
The corporate introduced it had scooped up $5 million in February 2021. Rhino’s whole funding pot now involves $11.7 million.
“The Rhino Well being Platform solves an actual want within the healthcare AI business — entry to bigger, extra various and evolving datasets. The progress we have made with our companions to date offers us nice confidence that distributed computing and federated studying are a game-changer for healthcare,” cofounder and CTO Yuval Baror stated in a press release. “Permitting healthcare organizations to maintain information inside their information methods, whereas offering builders a distributed computing platform to securely work with this information, will speed up the subsequent wave of healthcare innovation.”
Kyros, a platform that connects sufferers with substance use dysfunction with suppliers and different sources, raised one other $2.4 million in seed funding led by Rally Ventures, with participation from strategic angel traders.
The startup launched in Minnesota earlier this 12 months and introduced a $4.4 million seed raise in July. Kyros plans to make use of the funding to proceed growing its platform, develop into new markets and rent staffers.
